SPONSOR

University Health Network, Toronto

Total Trials

Recruiting

Phases

Phase 2, Phase 3, Phase 3, Phase 2, Phase 1

Conditions studied: Early Hepatocellular Carcinoma Endometrial Cancer Atypical Hyperplasia Bariatric Surgery Candidate Acute Graft Rejection Osteoarthritis, Knee Bladder Cancer Bladder Urothelial Carcinoma Advanced Cancer Pancreatic Cancer

University Health Network, Toronto is a clinical research sponsor with 32 registered studies on ClinicalTrials.gov, of which 32 are actively recruiting participants. Research covers conditions including Early Hepatocellular Carcinoma, Endometrial Cancer, Atypical Hyperplasia, Bariatric Surgery Candidate.

The trial portfolio spans Phase 2, Phase 3, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Health Network, Toronto

How many clinical trials has University Health Network, Toronto sponsored?

ClinicalMetric currently tracks 32 clinical trials sponsored by University Health Network, Toronto, of which 32 are actively recruiting participants. These trials cover conditions including Early Hepatocellular Carcinoma, Endometrial Cancer, Atypical Hyperplasia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Health Network, Toronto research focus on?

University Health Network, Toronto clinical trials span Early Hepatocellular Carcinoma, Endometrial Cancer, Atypical Hyperplasia, Bariatric Surgery Candidate, Acute Graft Rejection, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University Health Network, Toronto clinical trial?

To participate in a University Health Network, Toronto trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Health Network, Toronto trials with current recruitment status updated daily.

University Health Network, Toronto

Frequently Asked Questions — University Health Network, Toronto

Clinical Trials by University Health Network, Toronto

A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

Diagnosis of Graft Pathology by TruGraf

Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA

Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain

Study to Investigate an Association Between Brain Activity and Tidal Volume in Humans (BATMAN)

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer

SABR for Renal Tumors

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches

Hypersight and Ethos In Pediatric Radiotherapy

Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction

COgnitive-somatoSensory-MOtor Training to Improve Arm and Hand Function After Stroke (iCOSMO)

Deep Brain Stimulation of the Pedunculopontine Nucleus for Alzheimer's Disease

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

Registry for Patients Receiving Intravenous Nutrition at Home

Reducing Opioid Use for Chronic Pain Patients Following Surgery

Heart Rate VAriability as a MaRker for tItrATing hIgh flOw Nasal Cannula Therapy

Inhale and Exhale Breath Holds to Improve the Radiation Therapy Accuracy in People With Upper Abdominal Cancers

Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Talazoparib and Thoracic RT for ES-SCLC

Contrast-enhanced CBCT With C-arm HyperSight Technology

Cerebellar Deep Brain Stimulation for the Treatment of Ataxia

Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners

Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer

Radialis PET Imager for the Assessment of Neuritic Amyloid Plaque Burden

Effect of Hi-OxSR for the Treatment of Post COVID Condition

Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors

TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer

Stereotactic Radiotherapy (SBRT) of Lung Metastasis